Back to Top

Building Our Pipeline is Based on Collaboration

Clovis is focused on partnering with discovery-based companies and taking responsibility for developing and commercializing innovative products that may ultimately provide significant benefit to cancer patients.

Clovis is committed to oncology development, specifically, moving novel, targeted anti-cancer therapies through development and to the market in indications where significant unmet medical need exists or in subset patient populations where the compound may have significant promise.

If you would like additional information on partnering with us, or to discuss a compound currently in clinical development, please contact our business development team via email at